Journal of Advanced Pharmacy Education & Research
1:12-44 (2011)
16
toxicity [123] and contact urticaria [141]. The patented pharmaceutical compositions
are used for reducing hyperlipidemia, anti-platelet aggregation (US 4842859), wound
healing (US 5401504), control of hypertension and hypercholesterolemia (US 6162438),
hepatic and splenic disorders (US 20050074507), and for the treatment of osteoarthritis
(US 6492429).